scholarly article | Q13442814 |
P50 | author | Marc Dhenain | Q57780735 |
Clément M. Garin | Q88488658 | ||
P2093 | author name string | Sandro Alves | |
Véronique Blanchard | |||
Fanny Petit | |||
Emmanuel E Comoy | |||
Matthias Vandesquille | |||
Clémence Dudeffant | |||
Kelly Herbert | |||
P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice | Q24568007 | ||
Cerebrovascular disease in ageing and Alzheimer's disease | Q26771852 | ||
Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis | Q28088506 | ||
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase | Q28188098 | ||
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 | ||
Intracellular amyloid-beta in Alzheimer's disease | Q29615626 | ||
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers | Q29620245 | ||
High-field MRI of single histological slices using an inductively coupled, self-resonant microcoil: application to ex vivo samples of patients with Alzheimer's disease | Q33723162 | ||
Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion | Q34186434 | ||
Micro-MRI study of cerebral aging: ex vivo detection of hippocampal subfield reorganization, microhemorrhages and amyloid plaques in mouse lemur primates | Q34608330 | ||
Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging | Q34611770 | ||
Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer's disease | Q34658166 | ||
MRI detection of prion protein plaques in variant Creutzfeldt-Jakob disease. | Q35400644 | ||
Intraneuronal Abeta42 accumulation in human brain. | Q35793325 | ||
Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy | Q36707869 | ||
In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid Immunotherapy | Q36715449 | ||
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology | Q36724967 | ||
Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease | Q36821001 | ||
MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice | Q37295234 | ||
Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease | Q37732549 | ||
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice | Q38784401 | ||
Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease | Q39873732 | ||
In vivo measurement of plaque burden in a mouse model of Alzheimer's disease | Q40171019 | ||
Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain. | Q42084531 | ||
In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through? | Q42118376 | ||
In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice | Q42556926 | ||
In vivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system. | Q51892272 | ||
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice. | Q53318723 | ||
Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. | Q53376022 | ||
Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice. | Q53459115 | ||
Neuron loss in APP transgenic mice | Q59060085 | ||
cFos immunoreactivity is enhanced with biotin amplification | Q72864660 | ||
Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice | Q79322897 | ||
In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent | Q42556930 | ||
Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immuno | Q44020364 | ||
Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging | Q44264902 | ||
Morphological and carbogen-based functional MRI of a chemically induced liver tumor model in mice. | Q44562524 | ||
MR imaging features of amyloid-related imaging abnormalities. | Q44583188 | ||
Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor | Q44777442 | ||
In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography | Q45084871 | ||
Fast in vivo imaging of amyloid plaques using μ-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening | Q45327900 | ||
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease. | Q46067923 | ||
19F and 1H MRI detection of amyloid beta plaques in vivo | Q46379251 | ||
In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe | Q46440739 | ||
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. | Q46807855 | ||
Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography | Q46956780 | ||
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice | Q48127495 | ||
MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid | Q48199465 | ||
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease | Q48400715 | ||
Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. | Q48624844 | ||
Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease. | Q48654304 | ||
PET imaging with [18F]AV-45 in an APP/PS1-21 murine model of amyloid plaque deposition | Q48692645 | ||
Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome | Q48945429 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4955 | |
P577 | publication date | 2017-07-10 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains | |
P478 | volume | 7 |
Q64882641 | Assessment of pathological features in Alzheimer's disease brain tissue with a large field-of-view visible-light optical coherence microscope. |
Q98779313 | Ex-vivo Alzheimer's disease brain tissue investigation: a multiscale approach using 1060-nm swept source optical coherence tomography for a direct correlation to histology |
Q102388888 | Label-free X-ray estimation of brain amyloid burden |
Q55077627 | Localized instance fusion of MRI data of Alzheimer's disease for classification based on instance transfer ensemble learning. |
Q58722862 | Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review |
Q91555963 | RETRACTED ARTICLE: In situ structural characterization of early amyloid aggregates in Alzheimer’s disease transgenic mice and Octodon degus |
Q89640703 | Retinal analysis of a mouse model of Alzheimer's disease with multicontrast optical coherence tomography |
Q49832870 | Rodent Models of Cerebral Microinfarct and Microhemorrhage. |
Q64999742 | Supervised learning to quantify amyloidosis in whole brains of an Alzheimer’s disease mouse model acquired with optical projection tomography. |
Search more.